A detailed history of Nordea Investment Management Ab transactions in Pfizer Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 4,302,312 shares of PFE stock, worth $120 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,302,312
Previous 8,209,782 47.6%
Holding current value
$120 Million
Previous $236 Million 49.49%
% of portfolio
0.14%
Previous 0.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $101 Million - $116 Million
-3,907,470 Reduced 47.6%
4,302,312 $119 Million
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $6.8 Million - $8.84 Million
260,425 Added 3.28%
8,209,782 $236 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $13.3 Million - $15.6 Million
-415,454 Reduced 4.97%
7,949,357 $264 Million
Q2 2023

Jul 07, 2023

BUY
$36.12 - $41.79 $3.17 Million - $3.67 Million
87,755 Added 1.06%
8,364,811 $307 Million
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $344,150 - $448,033
8,737 Added 0.11%
8,277,056 $338 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $123 Million - $160 Million
-2,943,076 Reduced 26.25%
8,268,319 $424 Million
Q3 2022

Oct 19, 2022

SELL
$43.76 - $53.42 $43.3 Million - $52.8 Million
-988,585 Reduced 8.1%
11,211,395 $498 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $28 Million - $33.3 Million
-602,772 Reduced 4.71%
12,199,980 $626 Million
Q1 2022

Apr 11, 2022

SELL
$45.75 - $56.69 $11.8 Million - $14.6 Million
-257,549 Reduced 1.97%
12,802,752 $673 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $71.7 Million - $106 Million
1,734,078 Added 15.31%
13,060,301 $775 Million
Q3 2021

Nov 01, 2021

SELL
$39.25 - $50.42 $426 Million - $547 Million
-10,856,611 Reduced 48.94%
11,326,223 $496 Million
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $424 Million - $545 Million
10,810,020 Added 95.05%
22,182,834 $954 Million
Q2 2021

Jul 16, 2021

SELL
$35.91 - $40.68 $3.46 Million - $3.92 Million
-96,375 Reduced 0.84%
11,372,814 $445 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $16.9 Million - $19.1 Million
505,540 Added 4.61%
11,469,189 $414 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $6.87 Million - $8.73 Million
-205,189 Reduced 1.84%
10,963,649 $404 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $353 Million - $414 Million
-11,103,564 Reduced 49.85%
11,168,838 $406 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $265 Million - $321 Million
8,798,233 Added 65.3%
22,272,402 $691 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $40.3 Million - $57.6 Million
-1,492,418 Reduced 9.97%
13,474,169 $436 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $12.7 Million - $14.4 Million
-385,075 Reduced 2.51%
14,966,587 $582 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $11.8 Million - $15.3 Million
-363,955 Reduced 2.32%
15,351,662 $556 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $27.8 Million - $31.2 Million
-752,056 Reduced 4.57%
15,715,617 $681 Million
Q1 2019

May 20, 2019

SELL
$37.5 - $41.2 $12.5 Million - $13.8 Million
-334,660 Reduced 1.99%
16,467,673 $700 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $172 Million - $196 Million
-4,480,141 Reduced 21.05%
16,802,333 $734 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $185 Million - $224 Million
-5,365,568 Reduced 20.13%
21,282,474 $938 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $6.51 Million - $6.94 Million
-197,332 Reduced 0.74%
26,648,042 $967 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $344,053 - $399,149
-10,782 Reduced 0.04%
26,845,374 $953 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $39 Million - $41.4 Million
-1,172,834 Reduced 4.18%
26,856,156 $973 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $869 Million - $957 Million
28,028,990
28,028,990 $1 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.